These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 6656784

  • 1. Monkey models of tardive dyskinesia.
    Domino EF, Kovacic B.
    Mod Probl Pharmacopsychiatry; 1983; 21():21-33. PubMed ID: 6656784
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A monkey model of tardive dyskinesia (TD): evidence that reversible TD may turn into irreversible TD.
    Kovacic B, Domino EF.
    J Clin Psychopharmacol; 1982 Oct; 2(5):305-7. PubMed ID: 6890075
    [Abstract] [Full Text] [Related]

  • 4. Tardive dyskinesia controlled by anticholinergic agents.
    Monteiro LM.
    Clin Neuropharmacol; 1985 Oct; 8(4):372-6. PubMed ID: 4075305
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Regional changes in 2-deoxyglucose uptake associated with neuroleptic-induced tardive dyskinesia in the Cebus monkey.
    Mitchell IJ, Crossman AR, Liminga U, Andren P, Gunne LM.
    Mov Disord; 1992 Oct; 7(1):32-7. PubMed ID: 1557064
    [Abstract] [Full Text] [Related]

  • 7. The diagnosis of rapid abnormal involuntary movements associated with fluphenazine decanoate.
    Glazer WM, Moore DC.
    J Nerv Ment Dis; 1980 Jul; 168(7):439-41. PubMed ID: 7400795
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The effect of benztropine mesylate in the rabbit syndrome and tardive dyskinesia.
    Sovner R, Dimascio A.
    Am J Psychiatry; 1977 Nov; 134(11):1301-2. PubMed ID: 910992
    [No Abstract] [Full Text] [Related]

  • 10. Application of a primate model for tardive dyskinesia.
    Bárány S, Häggström JE, Gunne LM.
    Acta Pharmacol Toxicol (Copenh); 1983 Feb; 52(2):86-9. PubMed ID: 6846025
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Haloperidol-induced tardive dyskinesia in monkeys.
    Gunne LM, Bárány S.
    Psychopharmacology (Berl); 1976 Nov 24; 50(3):237-40. PubMed ID: 826968
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Fluphenazine decanoate. Its steady-state pharmacologic profile and relationship to tardive dyskinesia.
    Glazer WM.
    Schizophr Res; 1988 Nov 24; 1(6):425-9. PubMed ID: 3154530
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Fluphenazine decanoate and tardive dyskinesia.
    Schiff AA.
    Am J Psychiatry; 1982 Jul 24; 139(7):969-70. PubMed ID: 6124136
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.